Literature DB >> 19579645

Weekly paclitaxel therapy is effective for gastric adenosquamous carcinoma: a case report.

Tomoko Tohma1, Yoshikazu Yamamoto, Yukio Seki, Satoshi Takaishi, Youichi Sakuma, Yutaka Funami, Kouji Tobita.   

Abstract

A 65-year-old man was admitted for epigastralgia. On endoscopy, a type 3 cancer from the lower body of the stomach to the antrum was found, and abdominal CT scan demonstrated multiple liver metastases and peritoneal dissemination. A distal gastorectomy was performed. On, pathological examination, a diagnosis of adenosquamous carcinoma was confirmed, and lymph node metastases around the perigastric areas were found. The patient was given chemotherapy consisting of S-1 alone (120 mg/day, days 1-28 with two weeks rest). After two courses of chemotherapy, his liver metastases were found to have progressed, and paclitaxel was given at a weekly dose of 80 mg/m2 for 3 weeks, followed by a one-week rest. The carcinoembryonic antigen level decreased remarkably, and the liver metastases had decreased on CT. Thus, extensive chemotherapy for the liver metastases improved the patient's prognosis, while maintaining his quality of life.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19579645

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  5 in total

Review 1.  Adenosquamous carcinoma of the stomach and review of the literature.

Authors:  Yin-Yin Chen; Anna Fen-Yau Li; Kuo-Hung Huang; Yuan-Tzu Lan; Ming-Huang Chen; Yee Chao; Su-Shun Lo; Chew-Wun Wu; Yi-Ming Shyr; Wen-Liang Fang
Journal:  Pathol Oncol Res       Date:  2015-01-08       Impact factor: 3.201

2.  Clinicopathological characteristics, diagnosis, treatment, and outcomes of primary gastric adenosquamous carcinoma.

Authors:  Haining Chen; Chaoyong Shen; Rui Yin; Yuan Yin; Jiaju Chen; Luyin Han; Bo Zhang; Zhixin Chen; Jiaping Chen
Journal:  World J Surg Oncol       Date:  2015-04-02       Impact factor: 2.754

3.  A Nation-Wide Cancer Registry-Based Study of Adenosquamous Carcinoma in Taiwan.

Authors:  Yuan-Tzu Lan; Kuo-Hung Huang; Chien-An Liu; Ling-Chen Tai; Ming-Huang Chen; Yee Chao; Anna Fen-Yau Li; Shih-Hwa Chiou; Yi-Ming Shyr; Chew-Wun Wu; Wen-Liang Fang
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

4.  Durable response of human epidermal growth factor receptor-2-positive gastric adenosquamous carcinoma to trastuzumab-based chemotherapy.

Authors:  Shigenori Kadowaki; Yasushi Yatabe; Sohei Nitta; Yuichi Ito; Kei Muro
Journal:  Case Rep Oncol       Date:  2014-03-19

5.  Clinicopathological features and prognosis of gastric adenosquamous carcinoma.

Authors:  Fan Feng; Gaozan Zheng; Jingpeng Qi; Guanghui Xu; Fei Wang; Qiao Wang; Man Guo; Xiao Lian; Hongwei Zhang
Journal:  Sci Rep       Date:  2017-07-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.